Società Siegfried Holding AG

SFZN

CH0014284498

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Rating per Siegfried Holding AG

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Tempo reale stimato Cboe Europe Altri mercati azionari 16:27:13 03/07/2024			Variaz. 5gg	Var. 1 gen.
954,5 ^CHF	+1,76%		+3,25%	+10,88%

02/07	Siegfried finalizza l'acquisto del sito di sviluppo e produzione di Curia Global negli USA	MT
01/07	Siegfried Holding AG (SWX:SFZN) ha completato l'acquisizione del sito CDMO in fase iniziale a Grafton, Wisconsin, da Curia Global, Inc.	CI

Siegfried Holding AG è una società di scienze della vita con sede in Svizzera, attiva nella produzione primaria e secondaria di farmaci. L'azienda produce sia sostanze farmacologiche che prodotti farmaceutici. Il portafoglio di sostanze farmaceutiche comprende lo sviluppo e la produzione a contratto di ingredienti farmaceutici attivi (API) e intermedi. Il portafoglio di prodotti farmaceutici comprende licenze e contratti o co-sviluppo e produzione di solidi orali e sterili. I prodotti e le sostanze dell'Azienda sono sviluppati per il trattamento di ipertensione, iperplasia prostatica benigna, depressione, leucemia mieloide cronica, glaucoma, asma, schizofrenia e disturbi bipolari e diabete. L'Azienda gestisce impianti di produzione in Svizzera, Germania, Francia, Malta, Stati Uniti, Cina e Spagna.

Numero di dipendenti: 3 945

CHF in Milioni	2022	Peso	2023	Peso	Delta
Drug Substances 67,6 %	754	61,3 %	860	67,6 %	+14,10%
Drug Products 32,4 %	476	38,7 %	412	32,4 %	-13,51%

CHF in Milioni	2022	Peso	2023	Peso	Delta
Switzerland 100,0 %	1 230	100,0 %	1 271	100,0 %	+3,41%

Dirigenti	Titolo	Età	Da
Reto Suter CEO	Chief Executive Officer	53	01/05/17
Jürgen Roos CTO	Chief Tech/Sci/R&D Officer	56	01/04/19
Christa Brügger PRN	Corporate Officer/Principal	-	01/02/14
Marcel Imwinkelried PRN	Corporate Officer/Principal	57	01/01/21
Irene Wosgien HRO	Human Resources Officer	51	01/01/21
Marianne Späne PRN	Corporate Officer/Principal	62	01/06/04

Amministratori	Titolo	Età	Da
Martin Schmid BRD	Director/Board Member	55	01/01/16
Wolfram Carius BRD	Director/Board Member	63	01/01/14
Andreas Casutt CHM	Chairman	61	01/01/10
Beat Walti BRD	Director/Board Member	55	13/04/22
Isabelle Welton BRD	Director/Board Member	61	01/01/20
Alexandra Brand BRD	Director/Board Member	53	13/04/22
Elodie Carr-Cingari BRD	Director/Board Member	50	20/04/23

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	4 513 000	3 957 148 ( 87,68 %)	223 653 ( 4,956 %)	87,68 %

Nome	Azioni	%	Valorizzazione
Ernst Göhner Stiftung 5,008 %	226 000	5,008 %	225 M CHF
Interogo Foundation 4,967 %	224 167	4,967 %	223 M CHF
SIEGFRIED HOLDING AG 4,959 %	223 811	4,959 %	223 M CHF
BlackRock Fund Advisors 2,962 %	133 669	2,962 %	133 M CHF
Zürcher Kantonalbank (Investment Management) 2,947 %	132 977	2,947 %	133 M CHF
Credit Suisse Asset Management (Schweiz) AG 2,871 %	129 572	2,871 %	129 M CHF
Famiglia Braginsky 2,836 %	128 000	2,836 %	128 M CHF
Marianne Späne 0,7391 %	33 354	0,7391 %	33 M CHF
Wolfgang Wienand 0,6251 %	28 210	0,6251 %	28 M CHF
Andreas Casutt 0,4519 %	20 394	0,4519 %	20 M CHF

Nome	Azioni	%	Valorizzazione
SIEGFRIED HOLDING AG 4.96%	223 811	4.96%	223 029 528 $

Siegfried Holding AG

Untere Brühlstrasse 4

4800, Zofingen

+41 62 746 1111

http://www.siegfried.ch

Nome	Categoria e settore
Siegfried AG Siegfried AG Chemicals: AgriculturalProcess Industries Founded in 1873, Siegfried AG is a chemical product manufacturing company. The company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG.	Chemicals: Agricultural
Siegfried (USA), Inc. Siegfried (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried (USA), Inc. is a company that manufactures and supplies pharmaceutical products. The company is based in Pennsville, NJ.	Pharmaceuticals: Major
Siegfried Hameln GmbH Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany.	Pharmaceuticals: Major
BASF PharmaChemikalien GmbH & COKG BASF PharmaChemikalien GmbH & COKG Chemicals: Major DiversifiedProcess Industries Part of Siegfried Holding AG, BASF PharmaChemikalien GmbH & COKG is a German company that offers innovative products to meet the current and future needs of businesses and society. The company is based in Ludwigshafen, Germany. The company's product range can be found through industry research or their product search. The company's goal is to grow profitably and create value for society by creating chemistry for a sustainable future.	Chemicals: Major Diversified
Siegfried Finance AG
BASF Pharma (St. Vulbas) SAS BASF Pharma (St. Vulbas) SAS Chemicals: SpecialtyProcess Industries BASF Pharma (St. Vulbas) SAS manufactures basic organic chemicals. The company is headquartered in Saint-Vulbas, France.	Chemicals: Specialty
Siegfried St. Vulbas SASU Siegfried St. Vulbas SASU Pharmaceuticals: MajorHealth Technology Part of Siegfried Holding AG, Siegfried St. Vulbas SASU is a pharmaceutical and French chemical company that offers integrated partnership benefits to its customers. The company is based in Saint-Vulbas, France. The company combines a long tradition of pharmaceutical and chemistry with the innovative approach of an "integrated supplier" to provide more synergy, expertise, and value. The company was founded in 1992. Philippe Moy has been the CEO of the company since 2020.	Pharmaceuticals: Major
Siegfried PharmaChemikalien Minden GmbH Siegfried PharmaChemikalien Minden GmbH Chemicals: SpecialtyProcess Industries Part of Siegfried Holding AG, Siegfried PharmaChemikalien Minden GmbH produces pharmaceutical ingredients. The company is based in Minden, Germany. The CEOs of the German company are Marco Millies, René Imwinkelried.	Chemicals: Specialty
Siegfried Evionnaz SA
Siegfried Pharma AG
Siegfried Malta Ltd.
Siegfried Hong Kong Ltd.
Siegfried Barbera SL	Pharmaceuticals: Other
Siegfried el Masnou SA	Pharmaceuticals: Other

Rating Trading

Rating Investimento

ESG Refinitiv

B+

Altri rating

Vendita

Buy

Raccomandazione media

Buy

Numero di analisti

Ultimo prezzo di chiusura

938 CHF

Prezzo obiettivo medio

1.016 CHF

Differenza / Target Medio

+8,30%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
SIEGFRIED HOLDING AG	+10,88%	4,45 Mrd
ELI LILLY AND COMPANY	+55,83%	816 Mrd
NOVO NORDISK A/S	+39,32%	634 Mrd
JOHNSON & JOHNSON	-7,52%	351 Mrd
MERCK & CO., INC.	+16,49%	323 Mrd
ABBVIE INC.	+7,45%	293 Mrd
ASTRAZENECA PLC	+13,25%	238 Mrd
ROCHE HOLDING AG	+0,86%	222 Mrd
NOVARTIS AG	+13,41%	218 Mrd
AMGEN INC.	+8,12%	167 Mrd

Prodotti farmaceutici - Altri